Skip to main content
All lobbying filings

RESOLUTION PUBLIC AFFAIRS, LLC

Lobbying for PFIZER · Rx Drug Manufacturer

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Lobbyists on this filing 5
  • HEATHER MCHUGH
    Previously held: Legislative Director, Senator Schumer (2010-2013); Legislative Director, Congressman Israel (2003-2007); Legislative Assistant, Congresswoman Velazquez (2000-2003).
  • LEA FISHER SULKALA
    Previously held: Chief of Staff, Congresswoman Linda Sanchez (2014-2019); Legislative Assistant, Congressman Etheridge (2001-2005)
  • ELIZABETH GREY STANLEY
    Previously held: Part time employee, Congressman Joe Morelle (2021); Chief of Staff, Congresswoman Lowey (2005-2019); Communications Dir/Press Sec, Congresswoman Lowey (2001-2004); Special Assistant/Scheduler, Senator Schumer (1999-2000).
  • MEGHAN TAIRA
    Previously held: Senator Schumer, Legislative Director (2013-2025); Senator Schumer, Legislative Asssistant (2007-2013); Congresswoman DeGette, Health Policy Director (2002-2003)
  • ASHLI SCOTT PALMER
    Previously held: Floor Director, Majority Whip Clyburn (2019); Policy Director, Assistant Democratic Leader Clyburn (2014-2017); Chief of Staff, Rural Business Agency of USDA (2012-2014); Sr Legislative Assistant Congressman John Spratt (2002-2011).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act

Medicare/Medicaid

Direct-to-Patient Prescription Drug Purchase Platforms Most Favored Nation drug pricing 340B HHS Pilot Program Model

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem